MTA1 and vulvar carcinoma: In our analyses, the expression of MTA1 was increased in non-keratinized squamous cell carcinoma and vulvar carcinoma of the condylomatous type, although these two tumor subtypes were not simultaneously associated with a worse prognosis in our patient population.